Correlation Between Rekah Pharmaceutical and Clal Insurance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rekah Pharmaceutical and Clal Insurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rekah Pharmaceutical and Clal Insurance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rekah Pharmaceutical Industry and Clal Insurance Enterprises, you can compare the effects of market volatilities on Rekah Pharmaceutical and Clal Insurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rekah Pharmaceutical with a short position of Clal Insurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rekah Pharmaceutical and Clal Insurance.

Diversification Opportunities for Rekah Pharmaceutical and Clal Insurance

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Rekah and Clal is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Rekah Pharmaceutical Industry and Clal Insurance Enterprises in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Insurance Enter and Rekah Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rekah Pharmaceutical Industry are associated (or correlated) with Clal Insurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Insurance Enter has no effect on the direction of Rekah Pharmaceutical i.e., Rekah Pharmaceutical and Clal Insurance go up and down completely randomly.

Pair Corralation between Rekah Pharmaceutical and Clal Insurance

Assuming the 90 days trading horizon Rekah Pharmaceutical Industry is expected to generate 2.15 times more return on investment than Clal Insurance. However, Rekah Pharmaceutical is 2.15 times more volatile than Clal Insurance Enterprises. It trades about 0.14 of its potential returns per unit of risk. Clal Insurance Enterprises is currently generating about 0.25 per unit of risk. If you would invest  138,200  in Rekah Pharmaceutical Industry on September 1, 2024 and sell it today you would earn a total of  11,700  from holding Rekah Pharmaceutical Industry or generate 8.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rekah Pharmaceutical Industry  vs.  Clal Insurance Enterprises

 Performance 
       Timeline  
Rekah Pharmaceutical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Rekah Pharmaceutical Industry are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Rekah Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Clal Insurance Enter 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Clal Insurance Enterprises are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Clal Insurance sustained solid returns over the last few months and may actually be approaching a breakup point.

Rekah Pharmaceutical and Clal Insurance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rekah Pharmaceutical and Clal Insurance

The main advantage of trading using opposite Rekah Pharmaceutical and Clal Insurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rekah Pharmaceutical position performs unexpectedly, Clal Insurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Insurance will offset losses from the drop in Clal Insurance's long position.
The idea behind Rekah Pharmaceutical Industry and Clal Insurance Enterprises pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital